Coherus Biosciences

Cimerli - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5128

HCPCS Code Descriptor:

Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

Medicare Payment Limit:

The Cimerli Medicare Payment Limit is $256.167

Average Sale Price:

Cimerli ASP cost available once logged in. Cimerli is a biosimilar drug making the ASP calculation more complex. Cimerli's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The Cimerli Medicare Co-insurance percentage is 20%. Cimerli's Medicare Co-insurance amount is $51.23 per HCPCS unit.

APC Code:

The Cimerli APC Code is: 9117

APC Payment Limit:

The APC Payment Limit for Cimerli is available. Login to view.

Cimerli Cost Information:

Cimerli, a product of Coherus Biosciences, is aligned to HCPCS Q5128 and became effective on April 1, 2023. From its inception, AWP and WAC have remained constant while ASP has had a minimal decrease. As of 2024, ASP has decreased by almost 10%.

ACCESS PRICING AND MORE BY REGISTERING

Cimerli’s wholesale acquisition cost (WAC) information was last updated on:
October 3, 2022
Cimerli’s average wholesale price (AWP) information was last updated on:
October 3, 2022

Cimerli Cost Graph: